January 31, 2024 · Form 4 insider transaction
Shaw Kevin G. bought 66,125 shares of NextCure, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025.